Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies ... the prototype of the Squibb logo was designed. The logo represented product ...

Amy also shares the importance of getting to know the individuals behind the big Pharma logos, which helps patients ... dialogue that never existed before. Roche Diabetes Care in the US approached ...

Verdiva launches with an oversubscribed Series A financing of $411M, co-led by Forbion and General Atlantic, with additional participation from RA Capital Management, OrbiMed, Logos Capital ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Roche Pharma India has appointed Rajwinder Mehdwan as country General Manager, effective 1 April 2025. She will also join the leadership team of the Central Eastern Europe, Turkey, Russia and ...

Roche has given two early-phase bispecifics the heave-ho, ending work on a HER2xCD3 prospect and an IL-15 candidate it picked ...

Roche Pharma India has appointed Rajwinder (Rajji) Mehdwan as country general manager, effective 1st April, 2025. She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Roche will continue a careful approach to high-priced deals, putting science at the center of its business development ...

However, Roche's biologics focus (more than 80% of pharmaceutical sales) provides some buffer against the traditional intense declines from small-molecule generic competition. In addition ...

After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year ...